In addition to MTC, elevated calcitonin (CT) levels may be observed in patients with hypercalcemia, neuroendocrine tumors, renal insufficiency, PTC, FTC, and goiter (Toledo et al., 2009). Here, CALCA is linked to thyroid cancer, nonmedullary, 2.